company background image
A122310 logo

Genoray KOSDAQ:A122310 Stock Report

Last Price

₩6.24k

Market Cap

₩85.2b

7D

-0.6%

1Y

-13.7%

Updated

15 Jun, 2024

Data

Company Financials

A122310 Stock Overview

Engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea.

A122310 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

Genoray Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genoray
Historical stock prices
Current Share Price₩6,240.00
52 Week High₩8,590.00
52 Week Low₩5,880.00
Beta0.68
1 Month Change-4.15%
3 Month Change-6.02%
1 Year Change-13.69%
3 Year Change-40.29%
5 Year Change-10.22%
Change since IPO-49.88%

Recent News & Updates

Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems

Mar 28
Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems

Recent updates

Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems

Mar 28
Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems

Does Genoray Co., Ltd. (KOSDAQ:122310) Have A Place In Your Dividend Portfolio?

Apr 12
Does Genoray Co., Ltd. (KOSDAQ:122310) Have A Place In Your Dividend Portfolio?

Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?

Mar 01
Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?

We Like Genoray's (KOSDAQ:122310) Returns And Here's How They're Trending

Feb 11
We Like Genoray's (KOSDAQ:122310) Returns And Here's How They're Trending

Is Genoray Co., Ltd.'s (KOSDAQ:122310) Recent Performance Tethered To Its Attractive Financial Prospects?

Jan 27
Is Genoray Co., Ltd.'s (KOSDAQ:122310) Recent Performance Tethered To Its Attractive Financial Prospects?

Is Genoray Co., Ltd. (KOSDAQ:122310) A Smart Choice For Dividend Investors?

Jan 12
Is Genoray Co., Ltd. (KOSDAQ:122310) A Smart Choice For Dividend Investors?

Genoray Co., Ltd. (KOSDAQ:122310) Looks Interesting, And It's About To Pay A Dividend

Dec 24
Genoray Co., Ltd. (KOSDAQ:122310) Looks Interesting, And It's About To Pay A Dividend

A Look At The Fair Value Of Genoray Co., Ltd. (KOSDAQ:122310)

Dec 15
A Look At The Fair Value Of Genoray Co., Ltd. (KOSDAQ:122310)

We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt

Nov 30
We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt

Shareholder Returns

A122310KR Medical EquipmentKR Market
7D-0.6%4.9%1.1%
1Y-13.7%7.3%3.7%

Return vs Industry: A122310 underperformed the KR Medical Equipment industry which returned 7.3% over the past year.

Return vs Market: A122310 underperformed the KR Market which returned 3.7% over the past year.

Price Volatility

Is A122310's price volatile compared to industry and market?
A122310 volatility
A122310 Average Weekly Movement2.4%
Medical Equipment Industry Average Movement5.9%
Market Average Movement5.0%
10% most volatile stocks in KR Market11.2%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A122310 has not had significant price volatility in the past 3 months.

Volatility Over Time: A122310's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001268Byung Uk Parkwww.genoray.com

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide.

Genoray Co., Ltd. Fundamentals Summary

How do Genoray's earnings and revenue compare to its market cap?
A122310 fundamental statistics
Market cap₩85.22b
Earnings (TTM)₩12.60b
Revenue (TTM)₩103.61b

6.8x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A122310 income statement (TTM)
Revenue₩103.61b
Cost of Revenue₩63.89b
Gross Profit₩39.72b
Other Expenses₩27.12b
Earnings₩12.60b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)922.39
Gross Margin38.34%
Net Profit Margin12.16%
Debt/Equity Ratio13.0%

How did A122310 perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

17%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.